Nonlipid primary and secondary prevention strategies for coronary heart disease
- 1 May 1996
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 19 (5) , 419-423
- https://doi.org/10.1002/clc.4960190517
Abstract
Widespread application of proven primary and secondary preventive strategies for coronary heart disease would result in substantial savings of life and health care dollars. Proven strategies (excluding lipid therapy) include quitting smoking, treating hypertension, physical activity, aspirin therapy, and appropriate use of anticoagulants, beta blockers, and angiotensin-converting enzyme inhibitors in survivors of myocardial infarction. Estrogen replacement therapy is currently under clinical investigation. Avoidance of obesity and tight control of diabetes are prudent interventions as yet unproved by clinical trials. Unfortunately, preventive strategies are frequently underutilized. The greatest challenge for preventive cardiology is to put into practice what we already know to prevent the development and progression of atherosclerosis.Keywords
This publication has 26 references indexed in Scilit:
- Cost-effectiveness analysis in heart disease, part II: Preventive therapiesProgress in Cardiovascular Diseases, 1995
- Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.Circulation, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Statement on smoking and cardiovascular disease for health care professionals. American Heart Association.Circulation, 1992
- Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association.Circulation, 1992
- The Primary Prevention of Myocardial InfarctionNew England Journal of Medicine, 1992
- Proischemic complications of dihydropyridine calcium channel blockers.Circulation, 1991
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke CigarettesNew England Journal of Medicine, 1987
- Mortality in relation to smoking: 20 years' observations on male British doctors.BMJ, 1976